ECSP993178A - COMBINATORY THERAPY WITH RIBARVIRINE-INTERFERON ALPHA TO ERADICATE HCV-DETECTABLE RNA IN THOSE PATIENTS WITH CHRONIC HEPATITIS C INFECTION - Google Patents

COMBINATORY THERAPY WITH RIBARVIRINE-INTERFERON ALPHA TO ERADICATE HCV-DETECTABLE RNA IN THOSE PATIENTS WITH CHRONIC HEPATITIS C INFECTION

Info

Publication number
ECSP993178A
ECSP993178A ECSP993178A ECSP993178A EC SP993178 A ECSP993178 A EC SP993178A EC SP993178 A ECSP993178 A EC SP993178A EC SP993178 A ECSP993178 A EC SP993178A
Authority
EC
Ecuador
Prior art keywords
infection
chronic hepatitis
ribarvirine
interferon alpha
those patients
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Anil K Saksena
Raymond G Lovey
Frank Bennett
Ashit K Ganguly
Viyyoor Moopil Girijavallabhan
Jinping Mccormick
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP993178 priority Critical patent/ECSP993178A/en
Publication of ECSP993178A publication Critical patent/ECSP993178A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Un método para tratar un paciente que padece de una infección por hepatitis C crónica, a los efectos de erradicar el HCV-RNA detectable, que comprende una terapia combinatoria, la cual emplea una cantidad terapéuticamente efectiva de un derivado de ribavirina de la fórmula I y una cantidad terapéuticamente efectiva de interferón alfa, durante un lapso que varía entre 20 y 80 semanas.A method of treating a patient suffering from chronic hepatitis C infection, for the purpose of eradicating detectable HCV-RNA, comprising combinatorial therapy, which employs a therapeutically effective amount of a ribavirin derivative of formula I and a therapeutically effective amount of interferon alfa, over a period ranging from 20 to 80 weeks.

ECSP993178 1999-10-14 1999-10-14 COMBINATORY THERAPY WITH RIBARVIRINE-INTERFERON ALPHA TO ERADICATE HCV-DETECTABLE RNA IN THOSE PATIENTS WITH CHRONIC HEPATITIS C INFECTION ECSP993178A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP993178 ECSP993178A (en) 1999-10-14 1999-10-14 COMBINATORY THERAPY WITH RIBARVIRINE-INTERFERON ALPHA TO ERADICATE HCV-DETECTABLE RNA IN THOSE PATIENTS WITH CHRONIC HEPATITIS C INFECTION

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP993178 ECSP993178A (en) 1999-10-14 1999-10-14 COMBINATORY THERAPY WITH RIBARVIRINE-INTERFERON ALPHA TO ERADICATE HCV-DETECTABLE RNA IN THOSE PATIENTS WITH CHRONIC HEPATITIS C INFECTION

Publications (1)

Publication Number Publication Date
ECSP993178A true ECSP993178A (en) 2000-05-08

Family

ID=42044167

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP993178 ECSP993178A (en) 1999-10-14 1999-10-14 COMBINATORY THERAPY WITH RIBARVIRINE-INTERFERON ALPHA TO ERADICATE HCV-DETECTABLE RNA IN THOSE PATIENTS WITH CHRONIC HEPATITIS C INFECTION

Country Status (1)

Country Link
EC (1) ECSP993178A (en)

Similar Documents

Publication Publication Date Title
AR021226A1 (en) COMBINATORY THERAPY WITH RIBAVIRINA-INTERFERON ALFA TO ERADICATE DETECTABLE HCV-RNA IN THOSE PATIENTS WHO PRESENT INFECTION WITH CHRONIC HEPATITIS C
BR9812484A (en) Combination therapy for the eradication of detectable hcv-rna in patients with chronic hepatitis c infection
AR021876A1 (en) COMBINATION THERAPY FOR HCV INDUCTION OF RIBAVIRINA - INTERFERON ALFA PEGILADO
NZ507621A (en) HCV-RNA eradication in antiviral treatment naive patients having HCV genotypes 1, 2 or 3 using ribavirin and interferon alpha combination therapy
HK1052878A1 (en) Ribavirin-pegylated interferon alfa hcv combination therapy
AR023541A1 (en) HCV COMBINATION THERAPY
BR9911076A (en) Use of peg-ifn-alpha and ribavirin for the treatment of chronic hepatitis C
BR9809425A (en) Alpha interferon-polyethylene glycol conjugates for infection therapy
BR9915546A (en) Combination therapy of ribavirin-interferon alfa for the detection of detectable hcv-rna in patients with chronic hepatitis c infection
AR022116A1 (en) COMBINATION THERAPY FOR RHCAVIRINE INDUCTION HCV - INTERFERON ALFA
ECSP993178A (en) COMBINATORY THERAPY WITH RIBARVIRINE-INTERFERON ALPHA TO ERADICATE HCV-DETECTABLE RNA IN THOSE PATIENTS WITH CHRONIC HEPATITIS C INFECTION
CY1106388T1 (en) THERAPY OF HEPATITIS C WITH THYMOSIN, INTEPHON, AND RIBAVIRIN
AR013498A1 (en) USE OF IFN-ALPHA AND AMANTADINE FOR THE TREATMENT OF CHRONIC HEPATITIS C USE OF IFN-ALPHA
ECSP982669A (en) COMBINATION THERAPY TO ERADICATE DETECTABLE HCV-RNA IN PATIENTS WITH CHRONIC HETATITIS C INFECTION